Gamma-glutamylcysteine TFA (γ-Glutamylcysteine TFA) is an orally active, blood-brain barrier permeable dipeptide. It activates various signaling pathways like AMPK and Nrf2, while inhibiting others such as NF-κB and MAPKs. This compound regulates macrophage polarization, induces glutathione synthesis, improves metabolic dysfunction, and alleviates hepatic lipid droplet formation.
- Applicable to research related to inflammatory bowel disease.
- Applicable to research related to type 2 diabetes.
- Applicable to research related to cadmium-induced neurotoxicity.
- Applicable to research related to Alzheimer's disease.
- Applicable to research related to cerebral ischemia/reperfusion injury.
- Applicable to research related to neuropathy.
- Applicable to research related to alcoholic liver disease.